spective, non-randomized clinical trial evaluating the efficacy of atrial cardioversion in patients with chronic HF. A total of 282 patients from 41 institutions in the United States, Europe, and Japan who were successfully implanted with a CRT-D device (Concerto, Medtronic, Minneapolis, MN, USA) between January 27, 2006 and May 22, 2007 were included in this analysis. The detailed patient selection criteria have been previously described. 10 Briefly, patients were eligible if they had a standard indication for a CRT-D device, QRS duration ≥120 ms, New York Heart Association (NYHA) functional class III or IV HF, and left ventricular ejection fraction (LVEF) ≤35%, despite optimal medical therapy. Patients with permanent atrial fibrillation (AF) were excluded. All patients were required to meet all enrollment inclusion criteria, have no exclusion criteria, and provide written informed consent.
Intrathoracic Impedance Monitoring Algorithm
The CRT-D device used in the study had several additional diagnostic capabilities for HF management, including intrathoracic impedance monitoring. The details of the intrathoracic impedance monitoring and derived OptiVol fluid index algorithm used in the study device have been described in detail previously. 1,4, 6 In brief, intrathoracic impedance was calculated once daily as an average of 64 impedance measurements between the right ventricular defibrillation lead coil and the CRT-D device can, which was measured every 20 min from 12 PM to 5 PM, the best time of day to observe a fluid overload condition, in order to minimize the effects of respiration and posture on impedance. The daily impedance was compared with a reference, which tracked the trends in the preceding daily impedance values. The cumulative difference between the daily and reference impedances was used to calculate the OptiVol fluid index. The device was programmed to store the data if the fluid index increased above a programmed threshold, nominally set at 60 ohm-days, which came from the results of a previous study. 1 The fluid index was inactive for the first 34 days after device implantation to allow for 30 days of post-implant pocket healing and 4 days to draw the reference impedance.
Device Programming and Definitions
Baseline device programming including arrhythmic event detection and treatment was at the discretion of the implanting physician. A full interrogation of the CRT-D device was performed at each visit. Arrhythmic events implied there were either atrial or ventricular tachyarrhythmias. Atrial tachyarrhythmias included atrial tachycardia (AT), atrial flutter (AFL), and AF. Sustained ventricular tachycardia (VT) or fibrillation (VF) was considered a ventricular tachyarrhythmic event. Non-sustained or self-terminating VT was excluded from the analysis. Arrhythmic events that occurred within the first 34 days after the implant procedure were excluded from the analysis because the thoracic impedance fluid index had not been established. The study patients were classified into 2 groups: with and without OptiVol fluid index threshold crossings. Patient follow-up occurred at 1, 3, 6, and 12 months post-device implantation.
Statistical Analysis
Baseline characteristics were compared between the patients with and without a fluid index crossing. Exploratory analyses, including a contingency table analysis and univariate regression, were conducted to evaluate the association between fluid index crossings and patients' baseline characteristics such as age, sex, and cardiac disease history. The Poisson regression method was then applied to investigate whether a fluid index threshold crossing was a predictor of arrhythmic events after adjustment for the patient's baseline characteristics. 11 
Results

Study Patients
The baseline characteristics of all the study patients were described in detail previously. 10 In brief, 71% were male, 93% had NYHA class III HF, 56% had ischemic cardiomyopathy, and the median age was 68.3 years. The mean QRS duration was 157.0±23.4 ms, and the mean LVEF was 23.3±6.8%. Baseline medications included angiotensin-converting inhibitors or angiotensin receptor blockers (87%), β-blockers (88%), and diuretics (85%). In terms of a history of arrhythmias, 112 patients (40%) had atrial arrhythmias, including AT, AFL, and AF, and 129 (46%) had ventricular arrhythmias, including sustained VT (18%) and VF (10%), at baseline. The mean follow-up duration was 10.0±3.2 months.
Arrhythmic Events
A total of 4,725 arrhythmic events occurred at least 34 days post-device implantation in 129 (46%) study patients, including 3,521 atrial events in 90 patients and 1,204 ventricular events in 70 patients. Ventricular arrhythmic events were successfully treated with antitachycardia pacing in 897 (74.5%) and direct current shock deliveries in 107 (8.9%) episodes; 200 (16.6%) ventricular events were not treated because the cycle lengths of most of those events were detected as only being in the MONITOR zone, which was programmed by each of the investigators.
In the regression analysis, the exploratory variables considered for the analysis were threshold crossing events, patient sex, age at device implantation, baseline NYHA functional class, LVEF, QRS duration, and ischemic vs. non-ischemic HF. As a result, the arrhythmic events were significantly associated with the occurrence of a fluid index threshold crossing, higher NYHA class at baseline, female sex, and age ( Table 1) . In particular, the occurrence of a fluid index threshold crossing and higher NYHA class at baseline were strongly associated with arrhythmic events during the follow-up period (relative 
Association Between Intrathoracic Impedance and Arrhythmias
All 282 eligible study participants were grouped into 2 analysis cohorts: patients with at least 1 fluid index threshold crossing (TC (+) group, n=145) and those without a fluid index threshold crossing (TC (−) group, n=137). There were no significant differences between the 2 groups in the baseline characteristics ( Table 2) . Arrhythmic events in the TC (+) group occurred significantly more frequently than that in the TC (−) group (P<0.0001) ( Table 3) . Moreover, a statistically significant association was observed between fluid index threshold crossings and both atrial and ventricular arrhythmic events.
Time Course of Arrhythmic Events
In order to determine if intrathoracic impedance monitoring could be used as an indicator of the occurrence of arrhythmic events, the temporal relationship between the fluid index threshold crossings and subsequent arrhythmic events was investigated. Of the TC (+) group patients, 70 (48%) had at least 1 arrhythmic event during the follow-up period. Moreover, 45 of the TC (+) patients experienced arrhythmic events after a threshold crossing. Ventricular arrhythmic events occurred after a threshold crossing in 23 patients (16%) in the TC (+) group (Figure 1 ). An analysis of the time course of those ventricular arrhythmic events showed that a significantly greater proportion of ventricular arrhythmic events occurred within 1 month of a fluid index threshold crossing than occurred at least 1 month after a fluid index threshold crossing (55.8% vs. 44.2%, P=0.0359) (Figure 2) . In contrast, the proportion of atrial arrhythmic events occurring at least 1 month following a threshold crossing was significantly higher than that occurring within 1 month of a fluid index threshold crossing (54.9% vs. 45.1%, P=0.0004) (Figure 3) . In summary, ven- tricular arrhythmic events were more likely to occur within 1 month after a threshold crossing. However, no such trend was observed for the atrial arrhythmic events.
Discussion
Sudden cardiac death is often associated with severe HF, presumably because of ventricular tachyarrhythmias. 12- 14 The occurrence of ventricular arrhythmias may increase because of the existence of myocardial mechanoelectrical feedback 15, 16 or the hemodynamic consequences of sympathoadrenergic hyperactivity, 17 concomitant with deteriorating HF. Similarly, the prevalence of atrial tachyarrhythmias, including AF, increases with the severity of HF. 18-22 HF results in changes to the atrium that predispose it to the development and maintenance of atrial arrhythmias. 23 Decreased atrial refractory periods, slowed atrial conduction, or increased heterogeneity during atrial repolarization can promote the development and maintenance of atrial arrhythmias. 24 Prior studies have focused their attention on intrathoracic impedance as an indicator of HF decompensation. However, consideration has also been given to additional applications of intrathoracic impedance monitoring in the man- 25 Moore et al reported that ventricular arrhythmic episodes were preceded by cumulative differences between the averaged daily and reference impedance on the dates leading up to the ventricular arrhythmic events, which was used as a diagnostic indicator rather than the OptiVol fluid index. 26 As for atrial arrhythmic events, Jhanjee et al reported that worsening pulmonary congestion evidenced by fluid index threshold crossings was associated with an increase in the frequency of atrial arrhythmias, and that those arrhythmias may be responsible for triggering episodic pulmonary congestion more often than previously suspected. 27 Our retrospective observational study both confirmed and extended these findings by demonstrating a relationship between changes in intrathoracic impedance and the occurrence of cardiac arrhythmias within a large patient cohort. We investigated the temporal relationship between ventricular and atrial arrhythmic events and changes in intrathoracic impedance using the OptiVol fluid index. A multiple regression analysis revealed that both the occurrence of a fluid index threshold crossing and a higher NYHA class at baseline were independent predictors of atrial arrhythmic events, ventricular events, and the total number of arrhythmic events. Additionally, the patients with fluid index threshold crossings had significantly more atrial and ventricular arrhythmic events than those without threshold crossings during the follow-up period. These data suggest that cardiac arrhythmias are closely related to the fluid index threshold crossings, which in turn correlates with an increasing severity of HF. We, therefore, propose that changes in intrathoracic impedance can be regarded as a warning for cardiac arrhythmias, which tend to progress in parallel with exacerbation of HF.
Benefits of Early Warning of Cardiac Arrhythmias
Ventricular arrhythmic events sometimes result in the delivery of ICD shocks, which can be painful and increase the patient's anxiety. Additionally, Poole et al reported that the patients who received ICD shocks for arrhythmias had a substantially higher risk of death than similar patients who did not receive such shocks. 28 If changes in intrathoracic impedance can predict the occurrence of ventricular arrhythmias, effective early medical management may prevent the delivery of ICD shocks, resulting in a significant benefit to the patient.
Additional Considerations
The report by Moore et al 26 and our analysis suggest that the application of intrathoracic impedance monitoring as an indicator of the occurrence of ventricular arrhythmic events may lack specificity. Vollmann et al reported that the fluid index threshold crossing alert detected clinical HF deterioration with a 60% sensitivity (95%CI 46-73) and positive predictive value of 60% (95%CI 46-73) at the nominal threshold setting of 60 ohm-days. 5 Predicting the occurrence of an arrhythmia based on a cardiac overload that may result in HF cannot exceed the accuracy of predicting clinical HF deterioration using the intrathoracic impedance system. Furthermore, arrhythmias do not always appear at the time of HF deterioration. There also might be some prolonged cycle length ventricular events that are undetectable by the device programming, which induce cardiac deterioration and lead to a change in intrathoracic impedance. Thus, the observation that ventricular arrhythmias occurred after the threshold crossing in 16% of the TC (+) group patients in this study was reasonable and potentially clinically meaningful.
Although intrathoracic impedance measurements as currently implemented in implantable devices may not perform ideally as an indicator of arrhythmic events, tailored use in combination with consideration of the patient's history and the impedance trend at the time of the event may be useful. However, the hypothesis that changes in intrathoracic impedance predict the occurrence of arrhythmias requires prospective validation.
Study Limitations
This retrospective study is subject to the limitations of all such studies. First, no randomization or blinding was applied. Second, all arrhythmic events used for the analysis were based on the device diagnosis and the programmed settings determined only by the physician's discretion. The atrial arrhythmia detection criteria of the device requires an atrioventricular conduction of 2:1 or greater for a minimum of 32 ventricular cycles. Atrial arrhythmic events are detected when the median atrial cycle length is less than a minimum value programmed by the physician. Helmut et al reported that the positive predictive values of atrial arrhythmic episodes were 95.3% and 95.7% for previous devices. 29 The ventricular arrhythmia detection algorithm operates to discriminate between supraventricular and ventricular tachyarrhythmias based on atrial and ventricular depolarization timing, ventricular cycle length regularity, AF criteria and far-field criteria. 30, 31 Stadler et al demonstrated a positive predictive accuracy of 91.5% for the detection of ventricular arrhythmia episodes. 30 Third, the data for antitachycardia pacing episodes or direct current shock deliveries were not available for analysis in relation to the fluid index threshold crossings in this study. Finally, in regard to the fluid index setting, the nominal detection threshold value of 60 ohm-days used in this study demonstrated a 76.9% sensitivity in the large-scale observational study by Vollman et al. 5 However, some studies have reported that the positive predictive value of this proposed threshold for the OptiVol index related HF is relatively low. 1,4,32 Our data also showed that the fluid index threshold was crossed before atrial and ventricular arrhythmic events with a positive predictive value of 19% and 14%, respectively. The OptiVol index was developed to predict HF deterioration and may be affected by other events (eg, pneumonia, pleural effusion, pocket infection, drinking, etc). Ypenburg et al suggested that the nominal programmed fluid index threshold was not specific for the assessment of HF, and proposed that a threshold value of 120 ohm-days would provide a reasonable balance between sensitivity and specificity. 32 Further prospective studies in larger populations are needed to assess this hypothesis.
Conclusions
In this retrospective study of patients with NYHA class III and IV HF and who were implanted with CRT-D devices, arrhythmic events were associated with a dramatic change in the intrathoracic impedance-derived fluid index. Further prospective clinical trials are required to confirm the relationship between arrhythmic events and intrathoracic impedance monitoring, and to determine whether device-based fluid index monitoring can facilitate preemptive therapy to reduce the occurrence of arrhythmic events in patients with HF.
